secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2022-05-11T23:59:59+00:00
Accession:  0001077183-22-000083
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics names Vishal Sikri President of Inivata; Dr. Clive Morris retiring in June
--------------------------------------------------------------------------------

- Vishal Sikri appointed President and CCO of Inivata, effective May 23, 2022.
- Dr. Clive Morris to retire as President of Inivata effective June 30, 2022; settlement terms not yet determined.
- Dr. Gina Wallar, President of Pharma Services Division, resigning effective May 27, 2022; Jennifer Rose interim.
- Sikri receives base salary $510K, annual bonus target 50% of salary, sign-on bonus $500K, and equity grant $1.055M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000083/0001077183-22-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000083/neo-20220505.htm
  HTML page:      https://secwatch.observer/filing/0001077183-22-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer